vs
ASCENT INDUSTRIES CO.（ACNT）与Assertio Holdings, Inc.（ASRT）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是ASCENT INDUSTRIES CO.的1.1倍（$13.5M vs $11.9M），ASCENT INDUSTRIES CO.同比增速更快（13.3% vs -57.9%），过去两年ASCENT INDUSTRIES CO.的营收复合增速更高（-34.9% vs -35.4%）
阿森特工业（股票代码ACNT）前身为拆分自探索控股公司的独立上市媒体企业阿森特传媒，后转型为公开上市控股公司，核心子公司为莫尼特罗尼克斯，主营依托子公司开展安防相关业务运营。
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
ACNT vs ASRT — 直观对比
营收规模更大
ASRT
是对方的1.1倍
$11.9M
营收增速更快
ACNT
高出71.3%
-57.9%
两年增速更快
ACNT
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.9M | $13.5M |
| 净利润 | $-1.0M | — |
| 毛利率 | 14.6% | — |
| 营业利润率 | -21.0% | -86.7% |
| 净利率 | -8.8% | — |
| 营收同比 | 13.3% | -57.9% |
| 净利润同比 | -1.2% | — |
| 每股收益（稀释后） | $-0.11 | $-4.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACNTASRT
| Q4 25 | $11.9M | $13.5M | ||
| Q3 25 | $19.7M | $49.5M | ||
| Q2 25 | $18.7M | $29.2M | ||
| Q1 25 | $24.7M | $26.5M | ||
| Q4 24 | $10.5M | $32.2M | ||
| Q3 24 | $20.9M | $29.2M | ||
| Q2 24 | $21.5M | $31.1M | ||
| Q1 24 | $28.0M | $32.4M |
净利润ACNTASRT
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-2.1M | $11.4M | ||
| Q2 25 | $6.3M | $-16.4M | ||
| Q1 25 | $-2.3M | $-13.5M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-6.2M | $-2.9M | ||
| Q2 24 | $-926.0K | $-3.7M | ||
| Q1 24 | $-5.5M | $-4.5M |
毛利率ACNTASRT
| Q4 25 | 14.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 19.3% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 8.3% | — |
营业利润率ACNTASRT
| Q4 25 | -21.0% | -86.7% | ||
| Q3 25 | -4.1% | 23.2% | ||
| Q2 25 | -14.4% | -27.5% | ||
| Q1 25 | -4.2% | -50.0% | ||
| Q4 24 | -25.4% | -41.9% | ||
| Q3 24 | -9.4% | -10.4% | ||
| Q2 24 | -8.6% | -11.6% | ||
| Q1 24 | -15.5% | -13.4% |
净利率ACNTASRT
| Q4 25 | -8.8% | — | ||
| Q3 25 | -10.6% | 23.1% | ||
| Q2 25 | 33.7% | -56.0% | ||
| Q1 25 | -9.3% | -51.1% | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -29.5% | -10.0% | ||
| Q2 24 | -4.3% | -11.8% | ||
| Q1 24 | -19.7% | -13.9% |
每股收益（稀释后）ACNTASRT
| Q4 25 | $-0.11 | $-4.54 | ||
| Q3 25 | $-0.22 | $0.11 | ||
| Q2 25 | $0.65 | $-0.17 | ||
| Q1 25 | $-0.23 | $-0.14 | ||
| Q4 24 | $-0.11 | $-3.28 | ||
| Q3 24 | $-0.61 | $-0.03 | ||
| Q2 24 | $-0.09 | $-0.04 | ||
| Q1 24 | $-0.54 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.6M | $63.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $87.0M | $94.0M |
| 总资产 | $111.9M | $267.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACNTASRT
| Q4 25 | $57.6M | $63.4M | ||
| Q3 25 | $58.0M | $93.4M | ||
| Q2 25 | $60.5M | $98.2M | ||
| Q1 25 | $14.3M | $87.3M | ||
| Q4 24 | $16.1M | $100.1M | ||
| Q3 24 | $8.5M | $88.6M | ||
| Q2 24 | $3.6M | $88.4M | ||
| Q1 24 | $1.3M | $80.7M |
总债务ACNTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $38.6M |
股东权益ACNTASRT
| Q4 25 | $87.0M | $94.0M | ||
| Q3 25 | $87.1M | $105.8M | ||
| Q2 25 | $89.7M | $93.3M | ||
| Q1 25 | $91.2M | $108.5M | ||
| Q4 24 | $93.5M | $121.1M | ||
| Q3 24 | $94.7M | $130.5M | ||
| Q2 24 | $101.0M | $132.2M | ||
| Q1 24 | $102.0M | $134.5M |
总资产ACNTASRT
| Q4 25 | $111.9M | $267.0M | ||
| Q3 25 | $119.9M | $319.8M | ||
| Q2 25 | $122.6M | $273.8M | ||
| Q1 25 | $152.5M | $286.4M | ||
| Q4 24 | $147.3M | $284.7M | ||
| Q3 24 | $148.6M | $276.0M | ||
| Q2 24 | $158.2M | $279.4M | ||
| Q1 24 | $161.0M | $282.0M |
负债/权益比ACNTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0K | $-30.0M |
| 自由现金流经营现金流 - 资本支出 | $-196.0K | — |
| 自由现金流率自由现金流/营收 | -1.7% | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.1M | — |
8季度趋势，按日历期对齐
经营现金流ACNTASRT
| Q4 25 | $266.0K | $-30.0M | ||
| Q3 25 | $1.3M | $-4.8M | ||
| Q2 25 | $-1.4M | $19.1M | ||
| Q1 25 | $-700.0K | $-12.5M | ||
| Q4 24 | $8.8M | $11.5M | ||
| Q3 24 | $3.4M | $-35.0K | ||
| Q2 24 | $2.2M | $7.4M | ||
| Q1 24 | $263.0K | $7.5M |
自由现金流ACNTASRT
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $25.0K | — |
自由现金流率ACNTASRT
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 0.1% | — |
资本支出强度ACNTASRT
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.9% | — |
现金转化率ACNTASRT
| Q4 25 | — | — | ||
| Q3 25 | — | -0.42× | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
